CD44 and cancer: Shen et al. [88] demonstrated that hyaluronic acid functionalized lipid nanoparticles loaded with paclitaxel showed more efficient uptake over lipid nanoparticles without HA in B16F10 melanoma cells, facilitating delivery of the drug into these CD44-overexpressing cancer cells.